BridgeMD
New treatment option for Advanced Cancer
Official title Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy
ClinicalTrials.gov ID: NCT07009886
What this study is testing
- What it's testing
- To develop an educational patient decision aid for advanced cancer patients to prepare them to have conversations with their clinicians about treatment options (Treatments in Advanced cancer - Decision Aid, TA-DA).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Clinicians (Part I/II/III): MD Anderson medical oncologists and APPs who provide care to patients with advanced cancer
- Patients (Part I/II/III): Age 18 or over
- Diagnosis of advanced cancer (i.e., metastatic, relapsed, and/or incurable disease as defined by the treating oncologist) who has received at least 2...
- Patient-rated ECOG performance status of 1-3 for Part I/II and 2-3 for Part III
- Able to make treatment decisions based on the clinical judgement of the oncology team
You likely can't join if
- Any patient who meets any of the following criteria will be excluded from participation in this study:
- (Part I/II/III): Diagnosis of cognitive impairment or dementia requiring a surrogate decision maker as determined by the clinical team
- (Part III only): Participants in Part I and II
See the full eligibility criteria
- Clinicians (Part I/II/III): MD Anderson medical oncologists and APPs who provide care to patients with advanced cancer
- Patients (Part I/II/III): Age 18 or over
- Diagnosis of advanced cancer (i.e., metastatic, relapsed, and/or incurable disease as defined by the treating oncologist) who has received at least 2 lines of palliative systemic therapy\
- Patient-rated ECOG performance status of 1-3 for Part I/II and 2-3 for Part III
- Able to make treatment decisions based on the clinical judgement of the oncology team
- English speaking
- patient has started, is receiving, and/or has completed second-line palliative systemic therapy or beyond
- Caregivers (Part I/II/III):
- Age 18 or older
- Currently a primary caregiver to a patient who satisfies the patient eligibility criteria listed above
- For the study purposes, a primary caregiver is defined as:
- someone who provides physical, emotional, decisional and/or logistical assistance to the patient regularly (e.g. daily, weekly);
- can be a family member, friend, or other individual in a close relationship with the patient;
- must be identified by the patient and self-identify as the primary person providing caregiving support to the patient
- Able to provide informed consent and participate in the study
- English speaking
- Any patient who meets any of the following criteria will be excluded from participation in this study:
- (Part I/II/III): Diagnosis of cognitive impairment or dementia requiring a surrogate decision maker as determined by the clinical team
- (Part III only): Participants in Part I and II
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.